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ttp://dx.doi.org/10.1016/j.ajpath.2014.12.006The host response plays both protective and destructive roles in periodontitis. FOXO1 is a transcription
factor that is activated in dendritic cells (DCs), but its function in vivo has not been examined. We inves-
tigated the role of FOXO1 in activating DCs in experimental (CD11c.Creþ.FOXO1L/L) compared with matched
control mice (CD11c.Cre.FOXO1L/L) in response to oral pathogens. Lineage-speciﬁc FOXO1 deletion reduced
the recruitment of DCs to oral mucosal epithelium by approximately 40%. FOXO1 was needed for expression
of genes that regulatemigration, including integrinsa and b3 andmatrix metalloproteinase-2. Ablation of
FOXO1 in DCs signiﬁcantly decreased IL-12 produced by DCs in mucosal surfaces. Moreover, FOXO1 deletion
reduced migration of DCs to lymph nodes, reduced capacity of DCs to induce formation of plasma cells, and
reduced production of bacteria-speciﬁc antibody. The decrease in DC function in the experimental mice led
to increased susceptibility to periodontitis through a mechanism that involved a compensatory increase in
osteoclastogenic factors, IL-1b, IL-17, and RANKL. Thus, we reveal a critical role for FOXO1 in DC recruitment
to oral mucosal epithelium and activation of adaptive immunity induced by oral inoculation of bacteria.
(Am J Pathol 2015, 185: 1085e1093; http://dx.doi.org/10.1016/j.ajpath.2014.12.006)Supported by grants DE-017732 and DE-021921 from the National
Institute of Dental and Craniofacial Research (D.T.G.). Micro-CT imaging
was supported by grant P30 AR050950 from the Penn Center for Muscu-
loskeletal Disorders, National Institute of Arthritis and Musculoskeletal and
Skin Diseases, NIH.
Disclosures: None declared.Periodontitis is one of the most prevalent infectious diseases
worldwide and the most common cause of inﬂammatory bone
loss.1,2 Moderate to severe periodontal disease occurs in
approximately 30% of adults in the United States3 and is the
most frequent cause of tooth loss.4 The periodontium is a
complex set of tissues that is chronically exposed to large
numbers of bacteria that stimulate an inﬂammatory response,
which can induce periodontitis characterized by loss of sup-
porting connective tissue and alveolar bone around the
teeth.5,6 The innate and adaptive immune response induced by
infection rather than the direct pathologic effects of the bac-
teria stimulate periodontal tissue destruction.7,8 Immune cells,
such as polymorphonuclear leukocytes, monocytes or mac-
rophages, lymphocytes, and dendritic cells (DCs), have been
linked to periodontal disease in humans and experimental
animal models.2,5 Inﬂammatory cytokines and prostaglandins
play a critical role in promoting breakdown of connective
tissue and osteolysis.8e10
DCs in the oral mucosa detect bacteria and migrate into
regional lymph nodes, where they stimulate antigen-speciﬁcstigative Pathology.
.T- and B-cell proliferation, thereby initiating adaptive immune
responses,11 including transformation of B cells to plasma cells
that efﬁciently produce antibodies. Deletion of lymphocyte
subsets, such as CD4- and CD8-positive T cells, reduces peri-
odontal bone loss, whereas adoptive transfer of these cells
typically increases it.11,12 Lymphocyte products, particularly
IL-17, interferon (IFN)-g, and RANKL, are increased in peri-
odontal disease and functionally linked to periodontal break-
down in animal studies.13,14 Deletion of Langerhans cells, a
unique DC subset, leads to increased periodontal bone loss,
suggesting that these cells play a protective role.15 However, it
has also been proposed that the DCs promote periodontitis
through activation of the adaptive immune response and as a
source of osteoclast precursors that promote bone resorption.11
Xiao et alFOXO1, a member of the forkhead box O family of tran-
scription factors, plays an important role in the regulation of
many cellular and biological processes, including protection
against oxidative stress, promotion of apoptosis, and pro-
gression through the cell cycle.16 FOXO1 is involved in
immune responses by controlling cytokine production in a
number of cell types.16e18 We recently reported that FOXO1
mediates lipopolysaccharide-induced cytokine expression in
DCs.18 However, the role of FOXO1 in regulating the local
response of DCs to bacterial infection has not been previ-
ously investigated.
We examined CD11c.Creþ/.FOXO1L/L mice using the
lineage-speciﬁc ablation of FOXO1 to investigate its func-
tion in DCs in response to oral pathogens in vivo. We
hypothesized that the lack of FOXO1 in DCs would reduce
activation of the adaptive immune response and reduce
periodontal disease. Deletion of FOXO1 in DCs led to a
reduced DC function manifested by reduced DC expression
of IL-12 and a reduced capacity to stimulate an adaptive
immune response. This effect led to an increase in factors
that stimulate osteoclast formation, enhancing susceptibility
to periodontal bone loss.
Materials and Methods
Mice
CD11c-expressing Cre recombinase mice were purchased from
Jackson Laboratories (Bar Harbor, ME). FOXO1L/L mice
were generously provided by Dr. Ronald De Pinho (University
of Texas MD Anderson Cancer Center, Houston, TX).
FOXO1L/L mice were bred with CD11c.Cre recombinase mice
to generate the experimental mice (CD11c.Creþ.FOXO1L/L)
and the control mice littermates (CD11c.Cre.FOXO1L/L).
Other than the differences reported here, there were no obvious
phenotypic differences between the experimental and control
groups. All procedures were approved by the Institutional
Animal Care and Use Committee of the University of
Pennsylvania.
Bacteria and Oral Infection
Broth-grown Porphyromonas gingivalis (#33277; ATCC,
Manassas, VA) and Fusobacterium nucleatum (#25586;
ATCC) in logarithmic growth phase were collected and sus-
pended in sterile phosphate-buffered saline. Periodontal infec-
tion was induced by oral inoculation, three times per week for 2
weeks, with P. gingivalis and F. nucleatum, prepared as pre-
viously described.19 To reduce the original oral ﬂora, animals
were given sulfamethoxazole-trimethoprim, 10 mL per pint in
deionized water, drinking ad libitum for 10 days. Experimental
animals were given 109 colony-forming units of P. gingivalis
and 109 colony-forming units ofF. nucleatum suspended in 100
mL of 2% carboxymethyl cellulose in phosphate-buffered saline
(Sigma-Aldrich, St Louis, MO), which was directly inoculated
into the cavity. Controls consisted of sham-infected mice that1086received the antibiotic pretreatment and the carboxymethyl
cellulose oral inoculation without P. gingivalis and F. nuclea-
tum. Antibody titers generated to P. gingivalis are typically
higher than those to F. nucleatum. Because of limited serum
samples, we focused on P. gingivalis. AntieP. gingivalis IgG1
was measured by enzyme-linked immunosorbent assay as
previously described, and the concentration was determined by
reference to a standard curve.20
Flow Cytometry Analysis
Spleens were harvested from experimental mice
(CD11c.Creþ.FOXO1L/L) and the control littermates
(CD11c.Cre.FOXO1L/L). Splenocytes were isolated and
stained by speciﬁc antibodies (all from eBioscience, San
Diego, CA). DCs, T cells, and B cells were analyzed and
gated as CD11cþMHCIIþ, CD3þ, and B220þ cells by ﬂow
cytometry (FACS LSRII; BD Biosciences, San Jose, CA).
Bone marrowederived DCs from CD11c.Creþ.FOXO1L/L
and CD11c.Cre.FOXO1L/Lmice were cultured in vitro for 48
hours and then analyzed by ﬂow cytometry with DAPI la-
beling for the dead cells.
Alveolar Bone Loss
For microecomputed tomography (micro-CT) analysis, the
oral cavity was inoculated with bacteria as described above,
and mice were euthanized 6 weeks later. The mandible and
maxilla were dissected, ﬁxed for 24 hours in cold 10%
formalin, and prepared for micro-CT analysis using a micro-
CT-40 (Scanco Medical AG, Bassersdorf, Switzerland) to
assess periodontal bone levels as previously described.21 The
interproximal bone levels were established using the multi-
planar reconstruction tool using OsiriX software version
3.9.4 (Pixmeo, Geneva, Switzerland). For each group there
were six to seven mice. Histomorphometric analysis was
performed with Image ProPlus software version 7.0 (Media
Cybernetics, Silver Spring, MD). The bone loss was
measured by the length of bone crest to the cementoenamel
junction in the experimental group minus the distance in the
noninfected group. The attachment loss was measured by the
length from cementoenamel junction to the apical extent of
epithelium along the root surface.
Osteoclasts
Osteoclasts were identiﬁed and counted as multinucleated
tartrate-resistant acid phosphataseepositive bone-lining cells.
The region of interest was the coronal 0.35mm of alveolar bone
and gingiva as we have previously described.22
Immunohistochemistry
DCs in the gingiva and lymph nodes in vivo were measured
using a speciﬁc antibody to CD205 (NLDC145; Serotec,
Oxford, UK), a marker for DCs. Activated DCs wereajp.amjpathol.org - The American Journal of Pathology
Figure 1 Lineage-speciﬁc FOXO1 deletion in
CD11cþ cells does not affect the population of
dendritic cell (DCs), T cells, and B cells in spleen from
experimental mice (CD11c.Creþ.FOXO1L/L) compared
with the control littermates. A: FOXO1 expression in
DCs. RNA was isolated from puriﬁed splenic DCs,
T cells, and B cells from CD11c.Creþ.FOXO1L/L (gray
bars) and CD11c.Cre.FOXO1L/L (black bars) mice.
FOXO1 mRNA levels were measured by real-time PCR
and normalized to ribosomal protein L32. B: Bone
marrowederived DCs from CD11c.Creþ.FOXO1L/L and
CD11c.Cre.FOXO1L/L mice were cultured in vitro for
48 hours and then analyzed by ﬂow cytometry with
DAPI labeling for the dead cells. Alive cells desig-
nated as DAPI negative cells. CeE: Splenocytes from
experimental mice (CD11c.Creþ.FOXO1L/L) and the
control littermates (CD11c.Cre.FOXO1L/L) were
isolated and stained by speciﬁc antibodies. DCs, T
cells, and B cells were analyzed and gated as
CD11cþMHCIIþ, CD3þ, or B220þ cells by ﬂow
cytometry. The data represent two to three experi-
ments as similar results. *P < 0.05 between exper-
imental CD11c.Creþ.FOXO1L/L and littermate
CD11c.Cre.FOXO1L/L control mice. Sp-B, splenocyte
B cells; Sp-DC, splenocyte DCs; Sp-T, splenocyte
T cells.
FOXO1 Deletion in Dendritic Cellsidentiﬁed by dual immunoﬂuorescence with an antibody to
CD205 and an antibody to IL-12 (R&D Systems, Minneap-
olis, MN). The numbers of cells with co-localized CD205 and
IL-12 in the epithelium or connective tissue adjacent to the
epithelium were counted. Cells expressing RANKL (N-19;
Santa Cruze Biotechnology, Dallas, TX) near the bone surface
were detected by mean ﬂuorescence intensity. The number of
plasma cells in lymph nodes was measured using a speciﬁc
antibody to CD138 (BD Biosciences, San Jose, CA). Primary
antibody was detected by biotinylated secondary antibody
followed by ﬂuorescein-conjugated avidin (Vectastain ABC
kit; Vector Laboratories, Burlingame, CA) andmounting with
Fluoroshield (Sigma-Aldrich). To enhance the signal-to-noise
ratio, citrate (pH 6) antigen retrieval was used along with
tyramide signal ampliﬁcation that enhances the chromogenic
signal (PerkinElmer, Waltham, MA). Images were captured
with ﬂuorescencemicroscopy and analyzed using Nikon NIS-
Elements software version 3.2 (Nikon, Melville, NY).
Real-Time PCR
Total mRNA was extracted from gingiva dissected around
maxilla molars for the inﬂammation cytokines test. For FOXO1
expression,DCswere isolated frommouse spleens and enriched
by CD11cmicrobeads (Miltenyi Biotec, Auburn, CA) followed
by ﬂuorescence activated cell sorting (FACS Aria; BDThe American Journal of Pathology - ajp.amjpathol.orgBiosciences). DC purity was typically >95% as CD11cþ
MHCIIþB220NK1.1 cells. T cells were gated as CD90.2þ
B220 and B cells as CD90.2B220þ and were >95%
enriched. For DC migration, total RNA was isolated from the
bone marrow dendritic cells puriﬁed by CD11c microbeads
(Miltenyi Biotec).23 Relative mRNA levels were determined by
quantitative real-time PCR using Taq-Man primers and probe
sets (Applied Biosystems, Foster City, CA). Results were
normalized to a housekeeping gene, ribosomal protein L32. The
experiments were performedwith six to eight animals per group
with triplicate samples and performed two to three times with
similar results.
Statistical Analysis
The individualmousewas chosen as the unit of analysis. Results
are presented as themeans SEMof specimens. Statistical tests
were performed using one-way analysis of variance and
Student’s t-test. The signiﬁcance level was set at P < 0.05.Results
FOXO1 Expression
To establish that CD11c-driven Cre recombinase deletes
FOXO1 in CD11cþ dendritic cells but not T or B cells,1087
Figure 2 FOXO1 deletion reduces dendritic cell (DC) numbers in
bacteria-inoculated tissue and mRNA levels of genes needed for DC
migration. Mice were subjected to oral inoculation of the periodontal
pathogens Porphyromonas gingivalis and Fusobacterium nucleatum as
described in Materials and Methods. Six weeks later the periodontal tissue,
including the gingival mucosal epithelium, connective tissue, teeth, and
bone, was obtained. A and B: The number of DCs per area of epithelium (A)
and connective tissue (B) was measured as the number of CD205þ cells
using speciﬁc antibody CD205 compared with matched IgG control. C:
Mean ﬂuorescence intensity (MFI) of DCs in lymph nodes. DeF: Total RNA
was isolated from bone marrowederived DCs from experimental and
control mice. Integrins a (D), b3 (E), and matrix metalloproteinase
(MMP)-2 (F) mRNA levels were measured by real-time PCR normalized to
ribosomal protein L32 or 18S. The data are representative of two or three
separate experiments. *P < 0.05 between DCs from experimental
CD11c.Creþ.FOXO1L/L and littermate CD11c.Cre.FOXO1L/L control mice;
yP < 0.05 between noninfected and infected groups in littermate
CD11c.Cre.FOXO1L/L control mice and experimental CD11c.Creþ.FOXO1L/L
mice, respectively.
Xiao et alleukocytes were isolated from the spleen and puriﬁed by
ﬂuorescence activated cell sorting. FOXO1 mRNA levels
were reduced 93% in splenic DCs from experimental
CD11c.Creþ.FOXO1L/L mice compared with littermate1088controls (P < 0.05) but had no effect on mRNA levels in
puriﬁed T and B cells (P > 0.05) (Figure 1A). To establish
whether lineage-speciﬁc FOXO1 deletion in CD11cþ affects
the premature DC apoptosis, bone marrowederived DCs from
CD11c.Creþ.FOXO1L/L and CD11c.Cre.FOXO1L/L mice
were cultured in vitro for 48 hours and then analyzed by ﬂow
cytometry with DAPI labeling for the dead cells. Alive cells
dedicated as DAPI-negative cells, which revealed that pre-
mature DCs did not undergo apoptosis during 48-hour culture
and FOXO1 deletion did not affect DC survival (Figure 1B).
To establish whether lineage-speciﬁc FOXO1 deletion in
CD11cþ cells affects the population of DCs, T cells, and B
cells, ﬂow cytometry was performed. Splenocytes from
experimental mice (CD11c.Creþ.FOXO1L/L) and the
control littermates (CD11c.Cre.FOXO1L/L) were isolated
and stained by matched speciﬁc antibodies. DCs, T cells,
and B cells were analyzed and gated as CD11cþMHCIIþ,
CD3þ, or B220þ cells. The data revealed no difference of
DC, T-cell, and B-cell populations between experimental
and control littermates (Figure 1, CeE). Thus, lineage-
speciﬁc FOXO1 deletion in CD11cþ cells has no effect
on splenic DC, T-cell, and B-cell numbers.
DC Recruitment to Gingiva and Lymph Nodes Is FOXO1
Dependent
We determined whether deletion of FOXO1 in DCs would
affect the recruitment of DCs to gingiva, the site of oral
infection or draining cervical lymph nodes. The number of
DCs was measured using speciﬁc antibody to CD205, a
marker of DCs. Oral infection with periodontal pathogens
stimulated a 5.5-fold increase in the number of DCs in the
epithelium (P < 0.05) and 3.5-fold increase in the connec-
tive tissue in control mice (Figure 2, A and B). The number
of DCs was reduced by 36% in the epithelium and 32% in
the connective tissue of CD11c.Creþ.FOXOL/L mice
compared with control littermates (Figure 2, A and B). In
lymph nodes, the number of DCs was reduced by 37% in
the CD11c.Creþ.FOXOL/L mice compared with control
littermates (Figure 2C).
DC migration is affected by a number of different genes,
including chemokine receptor integrins a and b3, and by
matrix metalloproteinase-2.24,25 The effect of FOXO1 on
the mRNA levels of each was assessed. FOXO1 deletion in
experimental mice reduced mRNA levels for these genes by
approximately 50% (Figure 2, DeF).
Infection Stimulated DC Activity in Vivo Is FOXO1
Dependent
To test the capacity of DCs to activate lymphocytes in vivo,
the number of plasma cells was measured in the draining
lymph nodes by immunoﬂuorescence with antibody to
CD138 and by the production of antieP. gingivalis anti-
body. Infection stimulated a 2.3-fold increase in the number
of plasma cells in cervical lymph nodes (Figure 3, A and B).ajp.amjpathol.org - The American Journal of Pathology
Figure 3 FOXO1 deletion in dendritic cell (DC)
reduces stimulation of an adaptive immune
response and activation of DCs in gingival tissue.
Mice were infected by oral inoculation of the
periodontal pathogens Porphyromonas gingivalis
and Fusobacterium nucleatum as described in
Materials and Methods. A: Parafﬁn sections of neck
lymph nodes from CD11c.Creþ.FOXO1L/L mice or
control littermates mice were stained for plasma
cells by immunoﬂuorescence. CD138 (red) staining
decreases in CD11c.Creþ.FOXO1L/L mice relative to
control littermate mice after infection. B: The
number of plasma cells in lymph nodes were
quantiﬁed in immunoﬂuorescent images as
described in A. C: Experimental CD11c.Creþ.
FOXO1L/L (gray bars) and control CD11c.Cre.
FOXO1L/L (black bars) mice were administered
bacteria by oral inoculation. Controls consisted of
sham-infected mice that received the antibiotic
pretreatment and the carboxymethyl cellulose oral
inoculation. The level of P. gingivalisespeciﬁc
IgG1 was measured by enzyme-linked immunosor-
bent assay. D and E: The number of activated DCs
in vivo was measured using speciﬁc antibodies
(CD205, a marker for DC and IL-12, a cytokine pro-
duced by activated DCs) and three-color immuno-
ﬂuorescence. D: The number of DCs that produced
IL-12 in epithelium. E: The number of DCs that
produced IL-12 in connective tissue. *P < 0.05
between experimental CD11c.Creþ.FOXO1L/L and
littermate CD11c.Cre.FOXO1L/L control mice;
yP < 0.05 between noninfected and infected
groups in littermate CD11c.Cre.FOXO1L/L control
mice and experimental CD11c.Creþ.FOXO1L/L
mice, respectively. Scale bar Z 50 mm. Original
magniﬁcation: 400 (A).
FOXO1 Deletion in Dendritic CellsThe number of plasma cell was reduced by 57% in the
CD11c.Creþ.FOXOL/L mice compared with control littermates
(P < 0.05). The level of P. gingivalisespeciﬁc IgG1 was
measured in serum by enzyme-linked immunosorbent assay.
Infection stimulated a 4.3-fold increase in antieP. gingivalis
IgG1. This production was reduced 50% in the
CD11c.Creþ.FOXOL/Lmice compared with littermates that did
not have FOXO1 deleted in DCs (Figure 3C).
The effect of FOXO1 on DC activation was tested by
examining the number of DCs that expressed IL-12 after
infection. At baseline there was no difference between
experimental and control mice in IL-12eexpressing DCs
in the gingival epithelium or connective tissue (Figure 3, D
and E). Infection stimulated a ﬁvefold increase of
IL-12eexpressing DCs in the epithelium of control mice
and a similar increase in connective tissue (P < 0.05).
Lineage-speciﬁc FOXO1 deletion reduced the number of
CD205þIL-12þ DC cells in the gingival epithelium afterThe American Journal of Pathology - ajp.amjpathol.orginfection by 47% and by 48% in the gingival connective
tissue (Figure 3, D and E).
Increased Alveolar Bone Loss in CD11c.Creþ.FOXO1L/L
Mice
Susceptibility to periodontal disease was measured by
micro-CT and in histologic sections by loss of bone height
and loss of connective tissue attachment of the gingiva to
tooth surface. Infection stimulated 40% (maxilla) and 50%
(mandible) more bone loss in experimental CD11c.Creþ.
FOXO1L/L mice compared with the control mice littermates,
CD11c.Cre.FOXO1L/L (Figure 4A). Histologically, lineage-
speciﬁc deletion of FOXO1 resulted in a 63% greater loss
of bone height (Figure 4B) and 64% more loss of con-
nective tissue attachment (Figure 4C) in experimental
CD11c.Creþ.FOXO1L/L mice compared with the control
mice littermates, CD11c.Cre.FOXO1L/L.1089
Figure 4 FOXO1 deletion in dendritic cell (DC)
enhances susceptibility to periodontal disease.
Mice were infected by oral inoculation of the
periodontal pathogens Porphyromonas gingivalis
and Fusobacterium nucleatum as described in
Materials and Methods. A: The microecomputed
tomographic analysis of the periodontal bone was
examined in both the maxilla (left) and mandible
(right). B: Loss of bone height. C: Loss of con-
nective tissue attachment. D: Osteoclast count
over bone length. E: Eroded bone surface over
total bone surface. *P < 0.05 between experi-
mental CD11c.Creþ.FOXO1L/L and littermate
CD11c.Cre.FOXO1L/L control mice; yP < 0.05
between noninfected and infected groups in
littermate CD11c.Cre.FOXO1L/L control mice and
experimental CD11c.Creþ.FOXO1L/L mice, respec-
tively. BV, bone volume; TV, total volume.
Xiao et alTo account for the greater bone loss, we examined the
number of osteoclasts that were induced by bacterial infec-
tion. Periodontal infection induced twofold increase in the
number of osteoclasts compared with baseline (Figure 4D)
and a more than threefold increase in osteoclast activity
measured by eroded bone surface in mice with DC FOXO1
deletion (Figure 4E). In control littermates, the increase in
osteoclast numbers was reduced by 34% and osteoclast
activity by 47%.Differential Inﬂammatory Mediator Responses in
Periodontal Tissue after Infection
Because osteoclast formation and bone loss are tied to the
production of inﬂammatory mediators, we measured the ef-
fect of lineage-speciﬁc FOXO1 ablation on cytokines IL-1b
and IL-17 that promote periodontal bone loss.26,27 Infection
stimulated twofold higher levels of IL-1b and ﬁvefold higher
levels of IL-17 in control animals with bacterial infection
compared with baseline (Figure 5, A and B). The level of
these inﬂammatory cytokines was at least twofold higher in
the gingiva of experimental (CD11c.Creþ.FOXO1L/L) mice
compared with control littermates (P < 0.05). We also
measured RANKL expression in close proximity to bone by
immunoﬂuorescence because it is one of the principal
osteoclast-inducing factors.28 The mean ﬂuorescence
intensity of RANKL increased to 12-fold higher levels in
mice with DC FOXO1 deletion compared with matched
control mice (Figure 5C).1090Discussion
FOXO1 is a transcription factor that is needed for
expression of inﬂammatory mediators in cells that regulate
inﬂammation and DCs.16,18 This may be important in the
oral gingiva, where DCs and Langerhans cells have been
postulated to play a role in periodontal bone loss.15,18 Oral
inoculation of periodontal pathogens activates the adaptive
immune response to stimulate periodontal bone loss.5
Because some mice are resistant to induction of peri-
odontal disease, we infected mice with both P. gingivalis
and F. nucleatum, which induces periodontal disease more
reproducibly than either alone.29 This model replicates the
major events that occur in periodontal disease, including
the loss of connective tissue attachment and bone resorp-
tion.5 Using this model, we found that DC deletion of
FOXO1 reduces recruitment of DCs to oral mucosal
epithelium and connective tissue. This decreases activation
of adaptive immunity induced by oral inoculation of bac-
teria but leads to a compensatory increase in pro-
osteoclastogenic factors that enhance susceptibility to
periodontal bone loss.
Deletion of FOXO1 in DCs of experimental mice
induced greater bone loss compared with matched con-
trols. We found that the absence of FOXO1 in DCs led
to 50% more bone loss after infection. Consistent with
this observation, FOXO1 deletion in DCs signiﬁcantly
increased the number of osteoclasts and osteoclast activity
after infection with oral pathogens. The level of cytokines
that promote bone resorption was signiﬁcantly elevated byajp.amjpathol.org - The American Journal of Pathology
Figure 5 FOXO1 deletion increases the level of pro-osteoclastogenic cytokines. Mice were infected by oral inoculation of the periodontal pathogens
Porphyromonas gingivalis and Fusobacterium nucleatum as described in Materials and Methods. A and B: Total RNA was extracted from gingival tissue from
experimental (gray bars) and control (black bars) mice. IL-1b (A) and IL-17 (B) mRNA levels were measured by real-time PCR normalized to ribosomal protein
L32. C: RANKL expression was assessed by immunoﬂuorescence with anti-RANKL antibody compared with matched control IgG in the gingival connective tissue
in close proximity to bone. Data are presented as the mean ﬂuorescence intensity (MFI). *P < 0.05 between experimental CD11c.Creþ.FOXO1L/L and littermate
CD11c.Cre.FOXO1L/L control mice.
FOXO1 Deletion in Dendritic Cellslineage-speciﬁc deletion of FOXO1. IL-1b has been func-
tionally linked to alveolar bone resorption,26 which has been
shown to stimulate osteoclast formation by inducing
RANKL.28 RANKL directly stimulates osteoclastogenesis
and bone resorption.30 The role of IL-17 in periodontal disease
is less certain, although recent evidence indicates that inhibi-
tion of IL-17 can reduce periodontal bone loss in animal
models of periodontal disease and in bone destruction asso-
ciated with arthritis.26,31,32 In human studies, IL-1b, IL-17,
and RANKL levels are signiﬁcantly higher in patients with
periodontitis than in healthy controls.2,5,32 These results sug-
gest a mechanism whereby a decrease in DC FOXO1 leads to
up-regulation of the host response and greater expression of
proinﬂammatory cytokines that induce bone resorption,
particularly IL-1b, IL-17, and RANKL.
Oral infection with periodontal pathogens signiﬁcantly
increased the number of DCs in the mucosal epithelium and
subepithelial connective tissue of the gingiva. Periodontal
pathogens, such as P. gingivalis, stimulate DC activity.33 In
a human study, the number of DCs in the gingiva increased
as dental plague accumulated and decreased with plague
removal.34 The number of DCs in the gingival tissue was
signiﬁcantly reduced by DC deletion of FOXOL/L. This
ﬁnding is likely signiﬁcant because DCs, particularly in the
gingival epithelium, capture periodontal pathogens to
transport them to the lymph nodes and activate a humoral
antibody response.33 FOXO1 deletion also down-regulated
genes that play an important role in DCmigration, including
integrin a, integrin b3, and matrix metalloproteinase-2.
This decrease is likely to contribute to the reduced migra-
tion of DCs to gingival tissues in FOXO1-deleted mice. In
this study, FOXO1 deletion did not affect DC survival
in vitro; however, it is still a possibility that decreased DCThe American Journal of Pathology - ajp.amjpathol.orgsurvival in experimental animals reduced the number of
inﬁltrating DCs.
A critical aspect of DC behavior is homing to regional
lymph nodes.35,36 Oral infection stimulated an increase in
the number of DCs that homed to lymph nodes, which was
decreased in experimental CD11c.Creþ.FOXO1L/L mice
compared with control littermates. Because DCs may
directly stimulate B cells, we examined the effect of FOXO1
deletion on the capacity of DC to stimulate an adaptive
immune response after infection of mucosal surfaces.
FOXO1 deletion in DCs decreased stimulation of B cells to
form plasma cells in the lymph nodes. Plasma cell number
in the lymph nodes was reduced almost 60% in the
CD11c.Creþ.FOXO1L/L mice compared with control litter-
mates. In addition to decreased plasma cells, DC FOXO1
deletion reduced the formation of pathogen-speciﬁc anti-
body. The results suggest that FOXO1 is important in
regulating activity of DC that stimulates an adaptive im-
mune response. They are also consistent with the hypothesis
that antibodies against periodontal pathogens protect against
periodontal bone loss. In our study, the reduction in an
adaptive immune response resulted in a compensatory
increase in production of pro-osteoclastogenic cytokines
that lead to periodontal bone resorption. Similar results were
seen when lymphangiogenesis was blocked.37 In the latter
experiments, transgenic mice that have deﬁcient lym-
phangiogenesis (K14evascular endothelial growth receptor-
3eimmunoglobulin) exhibit a reduced humoral immune
response and an increased susceptibility to periodontal dis-
ease. The latter is manifested by a compensatory increase in
IL-1b and IL-17 and an increase in bacteria-induced bone
loss. Our results suggest a similar result with deletion of
FOXO1. Reduced FOXO1 in DCs leads to impaired1091
Xiao et alactivation of B cells in lymph nodes, which reduces anti-
body production, resulting in a compensatory increase in
cytokines that increase susceptibility to periodontal disease.
Thus, FOXO1 is an important transcription factor expressed
in DCs that may be necessary to generate a protective
humoral immune response.
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